There was one negative, the increased revenue did not translate into increased profits.
Slide 14 paints a very interesting picture.
Revenue + 25% - Good
Gross profit +24% - Good
NPATA + 10% - Not Good
There was a lot of leakage in S & M expenses, R & D (Ok with that - it is needed in their business) G & A and finance (understandable due to VIFOR acquisition).
I suspect that there will be some cost reduction occurring very soon in S & M to get Gross profit translating to NAPTA better.
HT1
Ann: CSL Half Year Results Announcement & Investor Presentation, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$265.47 |
Change
1.520(0.58%) |
Mkt cap ! $128.4B | |||
| Open | High | Low | Value | Volume |
| $264.45 | $265.51 | $259.33 | $103.0M | 391.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 106 | $265.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $265.50 | 23 | 5 |
View Market Depth
| Last trade - 13.50pm 23/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |